Which hedge funds own ALXO? ALX ONCOLOGY HLDGS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
5 of the hedge funds tracked by WhaleCreep disclosed a position in ALXO (ALX ONCOLOGY HLDGS INC) in their Q2 2026 13F filings, worth $37.8m in total. The largest holder by portfolio weight is RA Capital Management at 0.2% of its book. 1 manager opened a new position this quarter: Bronte Capital. 2 exited: Brevan Howard Capital Management, Point72 Asset Management LP.
5tracked managers holding
1opened this quarter
2exited this quarter
Which hedge funds hold ALXO? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.2% | $26.9m | 13,011,849 | 0% | held |
| Marshall Wace | Q2 2026 | 0.0% | $6.4m | 3,071,496 | -18% | reduced |
| Bronte Capital | Q2 2026 | 0.0% | $37.5k | 18,095 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $3.2m | 1,543,594 | -22% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.2m | 603,797 | -18% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $159.2k |
| Point72 Asset Management LP | 0.0% | $82.4k |
How has hedge fund ownership of ALXO changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $37.8m |
| Q1 2026 | 6 | $39.3m |
| Q4 2025 | 2 | $500.9k |
| Q3 2025 | 1 | $301.0k |
| Q2 2025 | 1 | $35.4k |
| Q1 2025 | 1 | $8.9k |
| Q3 2024 | 1 | $282.6k |
| Q2 2024 | 3 | $4.5m |
| Q1 2024 | 2 | $2.8m |
| Q4 2023 | 2 | $17.6m |
| Q3 2023 | 1 | $1.0m |
| Q2 2023 | 1 | $1.4m |
| Q1 2023 | 3 | $725.3k |
| Q4 2022 | 2 | $2.0m |
| Q3 2022 | 2 | $5.3m |
| Q2 2022 | 1 | $1.8m |
Counts every tracked manager that disclosed ALXO in that quarter's filing, including managers that have since stopped filing.